Cardioloxía Traslacional
Hospital Vall d'Hebron
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (5)
2023
-
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis
Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75
2022
-
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry
European Journal of Clinical Investigation, Vol. 52, Núm. 12
-
Sex Differences in Low-Density Lipoprotein Cholesterol Reduction with PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry
Journal of Cardiovascular Pharmacology, Vol. 79, Núm. 4, pp. 523-529
2013
-
Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years
Revista Portuguesa de Cardiologia, Vol. 32, Núm. 2, pp. 103-109
2011
-
Impacto de los nuevos criterios para el tratamiento anticoagulante de la fibrilación auricular
Revista Espanola de Cardiologia, Vol. 64, Núm. 8, pp. 649-653